Form 4: Twist Bioscience COO Sells Shares for Tax Obligations

Patrick John Finn, President and COO of Twist Bioscience Corp, sold 209 shares of common stock to cover tax withholding obligations related to the vesting of Restricted Stock Units.

Summary

• Patrick John Finn, President and COO of Twist Bioscience Corp (TWST), reported a transaction on July 2, 2025.
• The transaction involved the sale of 209 shares of common stock at a price of $36.193 per share.
• This sale was a 'sell to cover' transaction, mandated by the issuer's equity incentive plans to satisfy tax withholding obligations upon the vesting of Restricted Stock Units.
• The sale was explicitly stated not to be a discretionary trade by Mr. Finn.
• Following this transaction, Mr. Finn directly beneficially owns 240,574 shares of common stock.

Sentiment

Score: 5

Explanation: The transaction is a routine, non-discretionary 'sell to cover' for tax purposes, which is neutral in terms of market sentiment. It does not reflect a positive or negative view on the company's future performance by the insider.

Future Outlook

NA

Management Comments

• Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units.
• These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a 'sell to cover' transaction and do not represent discretionary trades by the Reporting Person.

Industry Context

NA

Stakeholder Impact

• The transaction is a routine administrative event for tax purposes related to executive compensation and is unlikely to have a direct material impact on shareholders, employees, customers, suppliers, or creditors.

Key Dates

Keywords

Twist Bioscience, TWST, Form 4, Insider Transaction, Beneficial Ownership, Patrick John Finn, Restricted Stock Units, RSU, Sell to Cover, Tax Withholding